XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.0.1
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Accumulated Other Comprehensive Income/(Loss)
Treasury Stock
Non - Controlling Interest
Beginning balance (in shares) at Dec. 31, 2018   37,850,544       3,628,068  
Beginning balance at Dec. 31, 2018 $ 618,319 $ 38 $ 364,179 $ 484,244 $ (83,467) $ (146,925) $ 250
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock issued against stock-based compensation plans (in shares)   630,110          
Stock issued against stock-based compensation plans 987 $ 1 986        
Stock-based compensation $ 26,070   26,070        
Acquisition of treasury stock (in shares) (643,486)         (667,345)  
Acquisition of treasury stock $ (41,364)         $ (41,364)  
Issuance of treasury stock 0            
Allocation of equity component related to issuance costs on convertible notes / Settlement of convertible notes (13)   (13)        
Purchase of non-controlling interest (232)   18       (250)
Other comprehensive loss (1,425)       (1,425)    
Net income 67,659     67,659      
Ending balance (in shares) at Dec. 31, 2019   38,480,654       4,295,413  
Ending balance at Dec. 31, 2019 670,001 $ 39 391,240 551,903 (84,892) $ (188,289) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock issued against stock-based compensation plans (in shares)   487,398          
Stock issued against stock-based compensation plans 1,501 $ 0 1,501        
Stock-based compensation $ 28,235   28,235        
Acquisition of treasury stock (in shares) (1,085,153)         (1,113,205)  
Acquisition of treasury stock $ (79,949)         $ (79,949)  
Issuance of treasury stock 0            
Other comprehensive loss 9,908       9,908    
Net income $ 89,476     89,476      
Ending balance (in shares) at Dec. 31, 2020 33,559,434 38,968,052       5,408,618  
Ending balance at Dec. 31, 2020 $ 719,172 $ 39 420,976 641,379 (74,984) $ (268,238) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Stock issued against stock-based compensation plans (in shares)   540,288          
Stock issued against stock-based compensation plans 710 $ 1 709        
Stock-based compensation $ 38,621   38,621        
Acquisition of treasury stock (in shares) (1,087,325)         (1,118,634)  
Acquisition of treasury stock $ (118,357)         $ (118,357)  
Issuance of treasury stock 36,742   19,436     $ 17,306  
Issuance of treasury stock (in shares)           310,394  
Allocation of equity component related to issuance costs on convertible notes / Settlement of convertible notes (84,000)   (84,000)        
Other comprehensive loss (14,490)       (14,490)    
Net income $ 114,758     114,758      
Ending balance (in shares) at Dec. 31, 2021 33,291,482 39,508,340       6,216,858  
Ending balance at Dec. 31, 2021 $ 693,156 $ 40 $ 395,742 $ 756,137 $ (89,474) $ (369,289) $ 0